Search Results - "Sedić, Mirela"
-
1
Sphingosine 1-Phosphate Signaling and Metabolism in Chemoprevention and Chemoresistance in Colon Cancer
Published in Molecules (Basel, Switzerland) (23-05-2020)“…Colorectal carcinoma (CRC) is the leading cause of cancer-related deaths worldwide. Despite advances in prevention and treatment modalities for CRC, rapidly…”
Get full text
Journal Article -
2
Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole–coumarin hybrids
Published in European journal of medicinal chemistry (29-11-2016)“…The 4-substituted 1,2,3-triazole core in designed coumarin hybrids (4–35) with diverse physicochemical properties was introduced by eco-friendly…”
Get full text
Journal Article -
3
Targeting Ceramide Metabolism in Hepatocellular Carcinoma: New Points for Therapeutic Intervention
Published in Current medicinal chemistry (01-01-2020)“…Hepatocellular Carcinoma (HCC) is one of the greatest global health burdens because of its uncontrolled cell growth and proliferation, aggressive nature as…”
Get more information
Journal Article -
4
Small Molecules Targeting Biological Clock; A Novel Prospective for Anti-Cancer Drugs
Published in Molecules (Basel, Switzerland) (26-10-2020)“…The circadian rhythms are an intrinsic timekeeping system that regulates numerous physiological, biochemical, and behavioral processes at intervals of…”
Get full text
Journal Article -
5
Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer
Published in European journal of medicinal chemistry (01-01-2018)“…A series of novel amidino 2-substituted benzimidazoles linked to 1,4-disubstituted 1,2,3-triazoles were synthesized by implementation of microwave and…”
Get full text
Journal Article -
6
The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein
Published in International journal of molecular sciences (01-10-2021)“…Vemurafenib (PLX4032), small-molecule inhibitor of mutated BRAFV600E protein, has emerged as a potent anti-cancer agent against metastatic melanoma harboring…”
Get full text
Journal Article -
7
Proteomic Profiling of BRAFV600E Mutant Colon Cancer Cells Reveals the Involvement of Nucleophosmin/c-Myc Axis in Modulating the Response and Resistance to BRAF Inhibition by Vemurafenib
Published in International journal of molecular sciences (08-06-2021)“…BRAFV600E mutations are found in approximately 10% of colorectal cancer patients and are associated with worse prognosis and poor outcomes with systemic…”
Get full text
Journal Article -
8
Targeting Tumour Metastasis: The Emerging Role of Nanotechnology
Published in Current medicinal chemistry (01-01-2020)“…The metastatic process has still not been completely elucidated, probably due to insufficient knowledge of the underlying mechanisms. Here, we provide an…”
Get more information
Journal Article -
9
Novel pyrimidine-2,4-dione–1,2,3-triazole and furo[2,3-d]pyrimidine-2-one–1,2,3-triazole hybrids as potential anti-cancer agents: Synthesis, computational and X-ray analysis and biological evaluation
Published in European journal of medicinal chemistry (05-01-2017)“…Regioselective 1,4-disubstituted 1,2,3-triazole tethered pyrimidine-2,4-dione derivatives (5–23) were successfully prepared by the copper(I)-catalyzed click…”
Get full text
Journal Article -
10
Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and β1 integrin/FAK−mediated signalling
Published in Biochemical and biophysical research communications (05-09-2018)“…Acid ceramidase (ASAH1) has been implicated in the progression and chemoresistance in different cancers. Its role in colon cancer biology and response to…”
Get full text
Journal Article -
11
Ezrin Inhibition Overcomes Acquired Resistance to Vemurafenib in BRAFV600E-Mutated Colon Cancer and Melanoma Cells In Vitro
Published in International journal of molecular sciences (01-08-2023)“…Despite the advancements in targeted therapy for BRAFV600E-mutated metastatic colorectal cancer (mCRC), the development of resistance to BRAFV600E inhibition…”
Get full text
Journal Article -
12
Proteomic study of medicinal mushroom extracts reveals antitumor mechanisms in an advanced colon cancer animal model via ribosomal biogenesis, translation, and metabolic pathways
Published in Frontiers in pharmacology (18-10-2024)“…Introduction Colorectal cancer ranks as the third most common cancer in both men and women, with approximately 35% of cases being stage IV metastatic at…”
Get full text
Journal Article -
13
Bioactive Sphingolipids as Biomarkers Predictive of Disease Severity and Treatment Response in Cancer: Current Status and Translational Challenges
Published in Anticancer research (01-01-2019)“…Recent translational studies in cancer have produced a wealth of evidence to support an association between sphingolipid metabolism and clinical outcomes,…”
Get full text
Journal Article -
14
Amidine- and Amidoxime-Substituted Heterocycles: Synthesis, Antiproliferative Evaluations and DNA Binding
Published in Molecules (Basel, Switzerland) (22-11-2021)“…The novel 1,2,3-triazolyl-appended N- and O-heterocycles containing amidine 4–11 and amidoxime 12–22 moiety were prepared and evaluated for their…”
Get full text
Journal Article -
15
Novel Bis- and Mono-Pyrrolo[2,3-d]pyrimidine and Purine Derivatives: Synthesis, Computational Analysis and Antiproliferative Evaluation
Published in Molecules (Basel, Switzerland) (01-06-2021)“…Novel symmetrical bis-pyrrolo[2,3-d]pyrimidines and bis-purines and their monomers were synthesized and evaluated for their antiproliferative activity in human…”
Get full text
Journal Article -
16
Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling
Published in Biochemical and biophysical research communications (10-06-2017)“…Hepatocellular carcinoma (HCC) represents the third leading cause of cancer-related deaths globally. Although 5-Fluorouracil (5-FU) is used as the first choice…”
Get full text
Journal Article -
17
Secretome Screening of BRAFV600E-Mutated Colon Cancer Cells Resistant to Vemurafenib
Published in Biology (Basel, Switzerland) (01-04-2023)“…Patients with metastatic colorectal cancer (mCRC) carrying BRAFV600E mutation have worse response to chemotherapy and poor prognosis. The BRAFV600E inhibitor…”
Get full text
Journal Article -
18
Novel 2-Thienyl- and 2-Benzothienyl-Substituted 6-(2-Imidazolinyl)Benzothiazoles: Synthesis; in vitro Evaluation of Antitumor Effects and Assessment of Mitochondrial Toxicity
Published in Anti-cancer agents in medicinal chemistry (2017)“…Differently substituted thiophenes are largely studied due to their diverse pharmacological properties, especially anticancer activity. Recent studies have…”
Get more information
Journal Article -
19
Coumarin‐modified ruthenium complexes: Synthesis, characterization, and antiproliferative activity against human cancer cells
Published in Archiv der Pharmazie (Weinheim) (01-09-2024)“…Among ruthenium complexes studied as anticancer metallodrugs, NKP‐1339, NAMI‐A, RM175, and RAPTA‐C have already entered clinical trials due to their potent…”
Get full text
Journal Article -
20
Novel 1,2,4-triazole and imidazole derivatives of l-ascorbic and imino-ascorbic acid: Synthesis, anti-HCV and antitumor activity evaluations
Published in Bioorganic & medicinal chemistry (01-06-2012)“…Several novel 1,2,4-triazole and imidazole l-ascorbic acid (1, 2, 3, 5, 6 and 9) and imino-ascorbic acid (4, 7 and 8) derivatives were prepared and evaluated…”
Get full text
Journal Article